Zykadia Tablet, Film Coated
Product Images NDC 0078-0694

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zykadia (NDC 0078-0694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Ceritinib Is Ceritinib Is A White To Almost White Or Light Yellow Or Light Brown Powder With A Pka Of 9.7 And 4.1. (Zykadia 01)

The Chemical Structure Of Ceritinib Is Ceritinib Is A White To Almost White Or Light Yellow Or Light Brown Powder With A Pka Of 9.7 And 4.1. (Zykadia 01)
Chemical structure of ceritinib, the active ingredient in ZYKADIA (150 mg) tablets, showing its molecular components and bonds as depicted in the image.*
FDA Label Image

Figure 1: Kaplan-meier Plot Of Progression-free Survival As Assessed By Birc By Treatment Arm In Ascend-4 (Zykadia 02)

Figure 1: Kaplan-meier Plot Of Progression-free Survival As Assessed By Birc By Treatment Arm In Ascend-4 (Zykadia 02)
A Kaplan-Meier survival curve comparing event-free probability over time (months) between patients treated with ZYKADIA (ceritinib) and chemotherapy. The chart includes patient counts at risk for each time point and censoring markers for ZYKADIA. The x-axis represents time in months, and the y-axis shows the percentage probability of being event-free.*
FDA Label Image

Principal Display Panelbottle Label – 150 mgrx Only Ndc 0078-0640-70zykadia (ceritinib) Capsules 150 mg70 Capsules (Zykadia 03)

Principal Display Panelbottle Label – 150 mgrx Only		Ndc 0078-0640-70zykadia (ceritinib) Capsules 150 mg70 Capsules (Zykadia 03)
Label for Zykadia (ceritinib) 150 mg film-coated tablets in a carton containing 84 tablets. The label includes the Novartis logo and states the product is Rx only. Storage instructions and manufacturer details (Novartis Pharma Produktions GmbH, Germany and Novartis Pharmaceuticals Corp., NJ) are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.